Adagene

Adagene

Adagene

Adagene is an antibody discovery and engineering company which seeks to establish technology-driven discovery partnerships.
Suggest edits
Type
B2c
Founded
2011
Raised
$147M
Follow us
Companies in the same industry
Alexa global traffic share
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3

Add info
Latest funding Show all
$69,000,000
Venture capital (Series D) - 2020
General Atlantic Sequoia Capital China F-Prime Capital +1
$50,000,000
Venture capital (Series C) - 2018
Sequoia China New World TMT AVIC Trust +2
Team Size
2
Employees
I work here
Location
China
Headquarters
Explore China
DealStreetAsia

Chinese biotech firm Adagene plans $200m US IPO

Adagene
Adagene
$69,000,000 Venture capital (Series D)
DealStreetAsia , FinSMEs

China-based drug developer Adagene raises $69m led by General Atlantic

Adagene
Adagene
$50,000,000 Venture capital (Series C)
PE HUB , AVCJ

Adagene raises $50 mln

Messaging Data leaks
Adagene
Adagene
FinSMEs

Adagene Raises $50M in Series C Funding

Funding
Adagene
Adagene
$28,000,000 Venture capital (Series B)
FinSMEs

Adagene Raises $28M in Series B Funding

Funding